Supernus Pharmaceuticals Inc (SUPN)
29.41
+0.53
(+1.84%)
USD |
NASDAQ |
Apr 19, 16:00
29.41
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Price: 29.41 for April 19, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 18, 2024 | 28.87 | 29.48 | 28.63 | 28.88 | 271363.0 |
| Apr 17, 2024 | 29.74 | 30.08 | 28.88 | 29.00 | 393830.0 |
| Apr 16, 2024 | 30.00 | 30.40 | 29.35 | 29.43 | 388897.0 |
| Apr 15, 2024 | 30.51 | 30.60 | 29.68 | 29.99 | 372719.0 |
| Apr 12, 2024 | 31.98 | 31.98 | 30.08 | 30.24 | 375040.0 |
| Apr 11, 2024 | 32.21 | 32.59 | 31.65 | 32.00 | 454386.0 |
| Apr 10, 2024 | 30.97 | 31.92 | 30.74 | 31.84 | 307449.0 |
| Apr 09, 2024 | 31.50 | 32.40 | 31.43 | 31.73 | 282392.0 |
| Apr 08, 2024 | 30.58 | 33.10 | 30.58 | 31.43 | 789685.0 |
| Apr 05, 2024 | 33.33 | 33.60 | 33.13 | 33.55 | 243132.0 |
| Apr 04, 2024 | 34.44 | 34.49 | 33.09 | 33.24 | 289968.0 |
| Apr 03, 2024 | 32.85 | 34.06 | 32.82 | 33.85 | 309453.0 |
| Apr 02, 2024 | 33.23 | 33.61 | 32.77 | 33.17 | 304043.0 |
| Apr 01, 2024 | 34.10 | 34.10 | 33.06 | 33.52 | 235971.0 |
| Mar 28, 2024 | 33.84 | 34.39 | 33.47 | 34.11 | 491007.0 |
| Mar 27, 2024 | 32.85 | 33.83 | 32.56 | 33.74 | 363964.0 |
| Mar 26, 2024 | 32.99 | 33.59 | 32.29 | 32.48 | 611763.0 |
| Mar 25, 2024 | 34.73 | 34.98 | 32.57 | 32.75 | 366595.0 |
| Mar 22, 2024 | 35.15 | 35.22 | 33.97 | 34.52 | 492786.0 |
| Mar 21, 2024 | 35.05 | 35.44 | 34.68 | 35.17 | 435839.0 |
| Mar 20, 2024 | 35.13 | 35.35 | 34.50 | 34.88 | 438140.0 |
| Mar 19, 2024 | 34.13 | 35.34 | 34.00 | 35.15 | 781195.0 |
| Mar 18, 2024 | 33.15 | 34.30 | 32.54 | 34.19 | 431863.0 |
| Mar 15, 2024 | 33.04 | 33.36 | 32.65 | 32.98 | 694833.0 |
| Mar 14, 2024 | 34.40 | 34.73 | 33.02 | 33.37 | 500838.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
14.45
Minimum
Mar 18 2020
42.03
Maximum
Feb 02 2023
28.82
Average
29.15
Median
Feb 18 2021
Price Benchmarks
| Dynavax Technologies Corp | 11.79 |
| Ligand Pharmaceuticals Inc | 72.55 |
| Pacira BioSciences Inc | 26.24 |
| Esperion Therapeutics Inc | 1.94 |
| Collegium Pharmaceutical Inc | 34.85 |
Price Related Metrics
| PS Ratio | 2.746 |
| Price to Book Value | 1.747 |
| Price to Free Cash Flow | 15.09 |
| Earnings Yield | -0.01% |
| Market Cap | 1.610B |
| Operating PE Ratio | 124.45 |
| Normalized PE Ratio | 110.18 |